Japanese drugmaker Eisai today revealed that it has launched its Urece (dotinurad) in China as a treatment for gout. Urece ...

Even as the US Food and Drug Administration (FDA) has unveiled a strategic expansion of its oversight mechanisms for foreign ...

South Korea’s Samsung Bioepis today published a whitepaper titled ‘Solving the Biosimilar Void in Europe’ that proposes ...

New figures in Danish pharma trade group Lif's Medicine Reimbursement Meter show a slight increase in the number of pharmacy ...

Ultragenyx Pharmaceutical (Nasdaq: RARE) has been dealt a regulatory setback, as the American medicines regulator has ...

US biotech Crinetics Pharmaceuticals (Nasdaq: CRNX) has released new data on its investigational oral therapy Palsonify (paltusotine), supporting its potential as a convenient alternative to monthly ...

The US Food and Drug Administration (FDA) last week authorized KalVista Pharmaceutical’s Ekterly for the treatment of acute ...

Data presented on the EURneffy/neffy adrenaline (epinephrine) nasal spray at the European Academy of Allergy & Clinical ...

A significant advancement in weight management has arrived for Singaporeans. Danish pharma Novo Nordisk has announced the ...

California-based Renasant Bio announced its launch to advance next-generation disease-modifying treatments for autosomal ...

CSL Seqirus, a subsidiary of Australia’s CSL Limited, said it has commenced shipping its differentiated portfolio of ...

US biotech Capricor Therapeutics today revealed receipt of a Complete Response Letter (CRL) from the US Food and Drug ...